Home » Agilent, MRM Proteomics Extend Co-marketing Agreement

Agilent, MRM Proteomics Extend Co-marketing Agreement

Jul 24, 2014
|
staff reporter

NEW YORK (GenomeWeb) – Agilent Technologies today announced the extension of a co-marketing agreement with MRM Proteomics.

The extension expands a deal between the companies reached in September 2012, and will allow the partners to improve their combined proteomics solutions comprising reagents kits, hardware, and software, Agilent said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Helix Launches 'App Store'

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

More CAR-T Therapies Sought

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Telomeres of Spawning Salmon

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

This Week in PLOS

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

What's Popular?

In Proteomics & Protein Research

  1. FDA, NCI Memorandum Indicates Growing Interest in Proteogenomics as Clinical Approach

    Premium

  2. WUSTL Team Develops Blood-Based Test for Brain Amyloidosis

    Premium

  3. NCI, FDA Sign MOU on Proteogenomics Research

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.